Mark Cooper is an experienced leader in clinical operations, currently serving as the Head of Clinical Operations Program Management (Respiratory) at AstraZeneca since 2025. Mark's career includes significant roles such as Executive Director of Late Clinical Operations at AstraZeneca (2022-2024) and Senior Vice President of Clinical Operations at Renovo Ltd (2004-2011). Previously, Mark held various positions at Pfizer and Simbec Research Limited, among others. Mark earned a Master of Science in Clinical Research from Cardiff University, complementing a Bachelor of Science in Biology.
This person is not in any teams
This person is not in any offices